MedPath

The effect of vitamin A, B, C, D, and E supplementations in COVID-19

Phase 2
Conditions
COVID-19.
COVID-19, virus identified
U07.1
Registration Number
IRCT20151226025699N5
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
135
Inclusion Criteria

Written consent for participation
Age over 34 years
A diagnosis of COVID-19 based on symptoms such as severe pneumonia, fever, fatigue, dry cough, respiratory distress, and lungs involvement in the computed tomographic (CT) scan according to the doctor's confirmation
Awareness score of at least 3 based on the 15-point Glasgow Coma Score (GCS)

Exclusion Criteria

Not tendency to participate in the study
Diagnosed cardiovascular and lung diseases which can disturb the study process
A diagnosis of malignant tumors
Recent use of chemotherapy drugs
Having incomplete medical records
Non-compliance with the vitamin A, B, C, D, and E supplementations
Consumption of vitamin A, B, C, D, and E supplementations during the last 3-month before the study
Pregnancy in women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath